Il Hwan Lee

Title: Il Hwan Lee: Innovator in Alzheimer's Disease Detection

Introduction

Il Hwan Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. His innovative work focuses on the detection of beta amyloid protein, which is a key factor in the development of this debilitating condition.

Latest Patents

Il Hwan Lee holds a patent titled "Detection of beta amyloid protein as Alzheimer's disease-causing factor in palatine tonsil and use thereof." This patent relates to the diagnosis of Alzheimer's disease by identifying the expression of beta amyloid in tonsillar samples. The method described in the patent allows for the diagnosis of Alzheimer's disease through the expression of beta amyloid in palatine tonsil tissue. This innovative approach not only aids in diagnosis but also has the potential to reveal the pathogenesis of Alzheimer's disease and contribute to its treatment. He has 1 patent to his name.

Career Highlights

Il Hwan Lee is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation. His work at this institution has allowed him to collaborate with other researchers and contribute to advancements in medical science.

Collaborations

Some of his notable coworkers include Sung Won Kim and Jung Ho Chun. Their collaborative efforts have further enhanced the research and development of diagnostic methods for Alzheimer's disease.

Conclusion

Il Hwan Lee's innovative contributions to the detection of Alzheimer's disease highlight the importance of research in medical diagnostics. His work not only aids in early diagnosis but also opens avenues for understanding and treating this complex disease.